日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting prostate cancer by new bispecific monocyte engager directed to prostate-specific membrane antigen

利用靶向前列腺特异性膜抗原的新型双特异性单核细胞衔接器治疗前列腺癌

Das, Gargi; Ptacek, Jakub; Campbell, Jana; Li, Xintang; Havlinova, Barbora; Noonepalle, Satish Kumar; Villagra, Alejandro; Barinka, Cyril; Novakova, Zora

Transcriptional regulator MarT negatively regulates MarT-regulated motility gene I, a new gene involved in invasion and virulence of Salmonella enterica

转录调节因子 MarT 负向调节 MarT 调节的运动基因 I,这是一种参与肠道沙门氏菌侵袭和毒力的新基因

Sebastián A Jerez #, Aracely Y Mora #, Ana R Millanao, Claudia P Saavedra, Sergio A Bucarey, Guido C Mora, Nicolás A Villagra, Alejandro A Hidalgo

The advances in targeting CD47/SIRPα "do not eat me" axis and their ongoing challenges as an anticancer therapy

CD47/SIRPα“别吃我”轴靶向治疗的进展及其作为抗癌疗法所面临的持续挑战

Gracia-Hernandez, Maria; Suresh, Manasa; Villagra, Alejandro

Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers

放射疗法可诱导前列腺癌患者产生先天免疫反应

Cheema, Amrita K; Li, Yaoxiang; Ventimiglia, Mary; Kowalczyk, Keith; Hankins, Ryan; Bandi, Gaurav; Janowski, Einsley-Marie; Grindrod, Scott; Villagra, Alejandro; Dritschilo, Anatoly

Editorial: Genetic and Epigenetic Control of Immune Responses

社论:免疫反应的遗传和表观遗传调控

Noonepalle, Satish Kumar R; Karabon, Lidia; Chiappinelli, Katherine B; Villagra, Alejandro

Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer

恩替诺特联合恩扎卢胺治疗转移性去势抵抗性前列腺癌患者的I期研究

Lin, Jianqing; Elkon, Jacob; Ricart, Brittany; Palmer, Erica; Zevallos-Delgado, Christian; Noonepalle, Satish; Burgess, Brooke; Siegel, Robert; Ma, Yan; Villagra, Alejandro

CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma

基于CpG包覆普鲁士蓝纳米粒子的光热疗法联合抗CTLA-4免疫检查点阻断可对神经母细胞瘤产生显著的远隔效应

Cano-Mejia, Juliana; Shukla, Anshi; Ledezma, Debbie K; Palmer, Erica; Villagra, Alejandro; Fernandes, Rohan

Epigenetic therapy for ovarian cancer: promise and progress

卵巢癌表观遗传疗法:前景与进展

Moufarrij, Sara; Dandapani, Monica; Arthofer, Elisa; Gomez, Stephanie; Srivastava, Aneil; Lopez-Acevedo, Micael; Villagra, Alejandro; Chiappinelli, Katherine B

Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells

作者更正:选择性 HDAC6 抑制剂通过降低巨噬细胞的抗炎表型和下调肿瘤细胞中的免疫抑制蛋白,从而改善抗 PD-1 免疫检查点阻断疗法的疗效。

Knox, Tessa; Sahakian, Eva; Banik, Debarati; Hadley, Melissa; Palmer, Erica; Noonepalle, Satish; Kim, Jennifer; Powers, John; Gracia-Hernandez, Maria; Oliveira, Vasco; Cheng, Fengdong; Chen, Jie; Barinka, Cyril; Pinilla-Ibarz, Javier; Lee, Norman H; Kozikowski, Alan; Villagra, Alejandro

Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia

抑制 HDAC6 可作为慢性淋巴细胞白血病的治疗靶点

Maharaj, Kamira; Powers, John J; Achille, Alex; Deng, Susan; Fonseca, Renee; Pabon-Saldana, Mibel; Quayle, Steven N; Jones, Simon S; Villagra, Alejandro; Sotomayor, Eduardo M; Sahakian, Eva; Pinilla-Ibarz, Javier